Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,005 | 178 | 96.6% |
| Education | $126.00 | 3 | 3.0% |
| Consulting Fee | $14.07 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $626.32 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $377.20 | 6 | $0 (2017) |
| GENZYME CORPORATION | $368.10 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $345.52 | 14 | $0 (2024) |
| Amgen Inc. | $279.99 | 21 | $0 (2024) |
| Genentech USA, Inc. | $238.45 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $223.87 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $172.34 | 12 | $0 (2024) |
| Shire North American Group Inc | $143.59 | 4 | $0 (2018) |
| Blueprint Medicines Corporation | $113.13 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,068 | 48 | GlaxoSmithKline, LLC. ($313.81) |
| 2023 | $564.76 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($218.11) |
| 2022 | $216.66 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($45.56) |
| 2021 | $95.56 | 6 | AstraZeneca Pharmaceuticals LP ($26.15) |
| 2020 | $267.08 | 13 | AstraZeneca Pharmaceuticals LP ($123.63) |
| 2019 | $673.11 | 35 | Amgen Inc. ($170.98) |
| 2018 | $468.49 | 26 | Genentech USA, Inc. ($121.98) |
| 2017 | $791.06 | 16 | Teva Pharmaceuticals USA, Inc. ($377.20) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology and Neurology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Immunology | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 10/08/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Immunology and Neurology | ||||||
| 09/10/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Allergy | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: VACCINES | ||||||
| 09/06/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.56 | General |
| 08/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Allergy | ||||||
| 08/06/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 285 | 2,709 | $153,864 | $37,444 |
| 2022 | 10 | 303 | 2,373 | $182,051 | $44,002 |
| 2021 | 11 | 265 | 2,148 | $129,091 | $34,397 |
| 2020 | 10 | 207 | 2,030 | $102,083 | $24,018 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 87 | $31,774 | $9,501 | 29.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 59 | 2,090 | $41,800 | $7,641 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $25,850 | $6,073 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 59 | $14,764 | $4,440 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $16,698 | $3,981 | 23.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 11 | 205 | $10,529 | $2,669 | 25.4% |
| 95076 | Test for allergy using ingested items, initial 2 hours | Office | 2023 | 14 | 16 | $6,616 | $1,576 | 23.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 15 | 159 | $5,834 | $1,561 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 116 | $42,366 | $12,359 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $24,200 | $5,815 | 24.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 37 | 1,483 | $29,660 | $5,592 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 60 | $15,014 | $4,794 | 31.9% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2022 | 24 | 240 | $29,490 | $4,569 | 15.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 11 | 235 | $12,070 | $3,215 | 26.6% |
| 95076 | Test for allergy using ingested items, initial 2 hours | Office | 2022 | 25 | 27 | $11,164 | $2,874 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $9,075 | $2,508 | 27.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 12 | 126 | $4,623 | $1,273 | 27.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $4,390 | $1,003 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 62 | $22,644 | $6,509 | 28.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 36 | 1,313 | $26,260 | $5,115 | 19.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $14,850 | $3,688 | 24.8% |
| 95018 | Allergy testing with drugs or biologicals into or within the skin, immediate type reaction, including test interpretation and report | Office | 2021 | 16 | 160 | $4,800 | $3,267 | 68.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 42 | $10,510 | $3,226 | 30.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $10,527 | $2,747 | 26.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 11 | 190 | $9,758 | $2,714 | 27.8% |
About Dr. Margaret Co, MD
Dr. Margaret Co, MD is a Allergy healthcare provider based in Ridgewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568494128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margaret Co, MD has received a total of $4,145 in payments from pharmaceutical and medical device companies, with $1,068 received in 2024. These payments were reported across 182 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,005).
As a Medicare-enrolled provider, Co has provided services to 1,060 Medicare beneficiaries, totaling 9,260 services with total Medicare billing of $139,861. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Location Ridgewood, NJ
- Active Since 07/06/2006
- Last Updated 07/19/2012
- Taxonomy Code 207KA0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568494128
Products in Payments
- NUCALA (Biological) $508.21
- DUPIXENT (Biological) $414.25
- CINQAIR (Drug) $284.25
- CINRYZE (Drug) $253.59
- EVENITY (Biological) $203.65
- Xolair (Biological) $121.98
- FASENRA (Drug) $115.29
- Xhance (Drug) $112.10
- CUVITRU (Biological) $109.78
- TRELEGY ELLIPTA (Drug) $102.62
- Hizentra (Biological) $99.28
- ENTYVIO (Biological) $78.94
- STELARA (Biological) $72.22
- Prolia (Biological) $61.42
- SIMPONI ARIA (Biological) $59.61
- Odactra (Drug) $56.14
- Ozempic (Drug) $54.29
- VERQUVO (Drug) $47.06
- INJECTAFER (Drug) $44.09
- Xembify (Biological) $43.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.